Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06657547

Urinary Concentration After Salmeterol

Urinary Concentration After Salmeterol in Well-trained Men and Females

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
24 (estimated)
Sponsor
University of Copenhagen · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

The purpose of the project is to investigate urine concentration after inhalation of salmeterol. This will be examined following acute physical activity under both normal conditions and heated conditions.

Conditions

Interventions

TypeNameDescription
OTHERNormal conditionsParticipants are administered salmeterol, after which they perform various performance tests in normal conditions. Following the administration of salmeterol, urine samples are collected over the next 24 hours at intervals of 0.5, 1, 2, 4, 8, and 24 hours after administration.
OTHERHeated conditionsParticipants are administered salmeterol, after which they perform various performance tests in heated conditions. Following the administration of salmeterol, urine samples are collected over the next 24 hours at intervals of 0.5, 1, 2, 4, 8, and 24 hours after administration.
DRUGSalmeterol inhalation and urine samplesAfter the experimental day under normal conditions, all participants are administered 200 µg of salmeterol daily (8 puffs from the MDI device) during a 6-day intervention period. Two hours after inhalation, the participants collect spot urine samples at home

Timeline

Start date
2024-10-31
Primary completion
2026-12-31
Completion
2026-12-31
First posted
2024-10-24
Last updated
2025-04-09

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT06657547. Inclusion in this directory is not an endorsement.